日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A SARS-CoV-2 EG.5 mRNA vaccine induces a broad-spectrum immune response in mice

SARS-CoV-2 EG.5 mRNA疫苗可在小鼠体内诱导广谱免疫反应。

Wang, Hongyu; Peng, Qinhua; Dai, Xinxian; Ying, Zhifang; Wu, Xiaohong; Liu, Xinyu; Xu, Hongshan; Li, Jia; Shi, Leitai; Liu, Jingjing; Wang, Yunpeng; Zhao, Danhua; Huang, Yanqiu; Yang, Lihong; Yang, Ren; Yue, Guangzhi; Suo, Yue; Ye, Qiang; Cao, Shouchun; Li, Yuhua

Development and validation of a qPCR assay for the detection of residual host cell DNA in rabies vaccines produced in Vero cells

开发并验证一种用于检测Vero细胞生产的狂犬病疫苗中残留宿主细胞DNA的qPCR检测方法

Zhao, Danhua; Zong, Weiying; Wu, Wanxin; Li, Yuhua; Wu, Zongsong; Yang, Zhixing; Cao, Shouchun

A novel single-vector featuring bidirectional promoters for production of bispecific antibody against rabies virus.

一种新型的单载体,具有双向启动子,用于生产针对狂犬病毒的双特异性抗体。

Zhang Zhigao, Li Jia, Lin Guanfeng, Cao Shouchun, Wu Yingsong

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes

冻干人狂犬病疫苗的安全性和免疫原性:萨格勒布和埃森方案的3期临床试验

Li, Jia; Wu, Zhiang; Wu, Xiaohong; Wang, Yunpeng; Shi, Leitai; Zhao, Danhua; Liang, Haiyan; Mo, Zhaojun; Cao, Shouchun

Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10-60 Years Age Group: A Follow-Up Report Based on Phase III Clinical Trial

10-60岁年龄组狂犬疫苗不同免疫方案的免疫原性和持久性:基于III期临床试验的随访报告

Wang, Yunpeng; Wu, Zhiang; Li, Jia; Cao, Shouchun; Shi, Leitai; Zhao, Danhua; Mo, Zhaojun; Liang, Haiyan; Wu, Xiaohong

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults

中国成年人使用基于RBD的SARS-CoV-2 mRNA疫苗进行异源加强免疫的安全性和优异免疫原性

Liu, Xiaoqiang; Li, Yuhua; Wang, Zhongfang; Cao, Shouchun; Huang, Weijin; Yuan, Lin; Huang, Yi-Jiao; Zheng, Yan; Chen, Jingjing; Ying, Bo; Xiang, Zuoyun; Shi, Jin; Zhao, Jincun; Huang, Zhen; Qin, Cheng-Feng

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice

将肌内注射和鼻内同源初免-加强免疫方案与基于黑猩猩腺病毒的COVID-19疫苗相结合,可在小鼠体内诱导强效的体液和细胞免疫反应。

Li, Xingxing; Wang, Ling; Liu, Jingjing; Fang, Enyue; Liu, Xiaohui; Peng, Qinhua; Zhang, Zelun; Li, Miao; Liu, Xinyu; Wu, Xiaohong; Zhao, Danhua; Yang, Lihong; Li, Jia; Cao, Shouchun; Huang, Yanqiu; Shi, Leitai; Xu, Hongshan; Wang, Yunpeng; Suo, Yue; Yue, Guangzhi; Nie, Jianhui; Huang, Weijin; Li, Wenjuan; Li, Yuhua

Antigenic variations of recent street rabies virus

近期街头狂犬病毒的抗原变异

Wang, Wenbo; Ma, Jian; Nie, Jianhui; Li, Jia; Cao, Shouchun; Wang, Lan; Yu, Chuanfei; Huang, Weijin; Li, Yuhua; Yu, Yongxin; Liang, Mifang; Zirkle, Brett; Chen, Xiaojiang S; Li, Xuguang; Kong, Wei; Wang, Youchun

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial

上市前免疫原性和安全性:一项随机临床试验,研究对象为采用微载体培养技术生产的冻干纯化人二倍体细胞狂犬病疫苗。

Zhou, Xingyu; Wu, Xiaohong; Cai, Yong; Cao, Shouchun; Zhu, Xiaoping; Lv, Qiang; Chen, Huaigong; Shi, Leitai; Li, Jia; Wang, Xinjie; Li, Yuhua; Zhou, Rong

Comparison of serological assays to titrate Hantaan and Seoul hantavirus-specific antibodies.

比较血清学检测方法对汉坦病毒和首尔汉坦病毒特异性抗体的滴定效果

Li Weihong, Cao Shouchun, Zhang Quanfu, Li Jiandong, Zhang Shuo, Wu Wei, Qu Jing, Li Chuan, Liang Mifang, Li Dexin